Advance in Therapeutic Targets of Intrahepatic Cholangiocarcinoma

LIN Jian; WANG Haibo; SHEN Feng

doi:10.3971/j.issn.1000-8578.2021.20.1248

Zhongliu Fangzhi Yanjiu (Mar 2021)

Advance in Therapeutic Targets of Intrahepatic Cholangiocarcinoma

LIN Jian,
WANG Haibo,
SHEN Feng

Affiliations

LIN Jian: Department of Hepatic Surgery IV, The Eastern Hepatobiliary Surgery Hospital, Naval Military Medical University, Shanghai 200433, China
WANG Haibo: Department of Hepatic Surgery IV, The Eastern Hepatobiliary Surgery Hospital, Naval Military Medical University, Shanghai 200433, China
SHEN Feng: Department of Hepatic Surgery IV, The Eastern Hepatobiliary Surgery Hospital, Naval Military Medical University, Shanghai 200433, China

DOI: https://doi.org/10.3971/j.issn.1000-8578.2021.20.1248
Journal volume & issue: Vol. 48, no. 3
pp. 224 – 228

Abstract

Read online

Intrahepatic cholangiocarcinoma (ICC) is highly invasive and has poor prognosis. At present, there is no effective adjuvant treatment. With the indepth researches on ICC-related tumor microenvironment, gene, protein, epigenetic modification and signaling pathway, the potential therapeutic targets have been found. This article will review the novel potential therapeutic targets of ICC.

Published in Zhongliu Fangzhi Yanjiu

ISSN: 1000-8578 (Print)
Publisher: Magazine House of Cancer Research on Prevention and Treatment
Country of publisher: China
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: http://www.zlfzyj.com

About the journal

Abstract

Keywords